Page 13 - Nbfcs Msme Restructuring Scheme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nbfcs msme restructuring scheme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nbfcs Msme Restructuring Scheme Today - Breaking & Trending Today

bad loan: High EMD demand for bad loan bids discouraging ARC participation

While banks and NBFCs believe that a high EMD ensures participation from only serious and committed players and helps maintain confidentiality, several ARCs believe that this discourages wider participation. ....

Indian Banks Association , Earnest Money Deposits , Yes Bank , Bad Loan ,

it stocks outlook: Looking at a flattish quarter for Indian IT space for Q3: Ajay Bagga

Ajay Bagga expresses caution about the NBFC sector and expects a decline in revenues, margins, and growth trajectory. The truck and vehicle finance sectors are performing well, but the rural demand has not picked up. In the IT sector, there is a slowdown in orders, and companies need to focus on new revenue avenues such as artificial intelligence and cloud growth. ....

Uttar Pradesh , Ajay Bagga , Mukesh Ambani , Ather Energy , Offering College , Indian School Of Business , Market Expert , Shriram Finance , Leadership Excellence , Executive Officer , Marketing Officer , Might Also Like , Vibrant Gujarat , It Stocks Outlook , Fmcg Recovery , Consumer Stocks , Wipro And Hcl Technologies , Expert View , Stock Market , Et Now ,

pharma: Time to move to NBFCs, pharma; increase allocation to largecaps: Hemang Jani

Hemang Jani suggests moving allocation from midcap/smallcap companies to largecaps like Lemon Tree and Indian Hotels, as well as pharma and NBFCs. Reliance is expected to perform well due to Jio s growth and positive valuation. Moving 10-15% portfolio to largecaps is sensible. The NBFC sector is stabilizing, with Poonawalla Fincorp and LIC Housing expected to deliver strong results. Midcaps are still a good investment, but selective choices are important. The pharma sector has rebounded, with Cipla, Sun Pharma, Dr Reddy s, Laurus Labs, and Aurobindo Pharma as top bets. ....

Uttar Pradesh , Hemang Jani , Poonawalla Fincorp , Sun Pharma , Offering College , Indian Hotels , Independent Market Expert , Lemon Tree , Leadership Excellence , Executive Officer , Product Officer , Operations Officer , Might Also Like , Laurus Labs , Aurobindo Pharma , Stock Market , Reallocation Of Money , Expert View , Et Now ,